Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-22

Clinical Trial Update: REVEAL Study - Diagnostic Testing for PTSD Using the Senseye Diagnostic Tool [Phase 3]

View source ↗

Summary

The document reports a Phase 3 clinical trial (REVEAL) evaluating the Senseye Diagnostic Tool for diagnosing post-traumatic stress disorder and notes that it is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Senseye, Inc. | Conditions: PTSD - Post Traumatic Stress Disorder | Phase 3 | Status: RECRUITING